Woodline Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-278,223
Closed -$12.1M 700
2023
Q3
$12.1M Sell
278,223
-95,109
-25% -$4.14M 0.14% 199
2023
Q2
$13.5M Buy
373,332
+107,232
+40% +$3.87M 0.16% 171
2023
Q1
$9.89M Sell
266,100
-370,617
-58% -$13.8M 0.13% 200
2022
Q4
$28.8M Buy
636,717
+414,209
+186% +$18.8M 0.39% 60
2022
Q3
$15.5M Sell
222,508
-71,059
-24% -$4.96M 0.22% 138
2022
Q2
$19.7M Buy
293,567
+167,519
+133% +$11.2M 0.3% 97
2022
Q1
$10.4M Buy
126,048
+1,156
+0.9% +$95K 0.17% 169
2021
Q4
$18.3M Buy
124,892
+11,749
+10% +$1.72M 0.26% 114
2021
Q3
$20M Buy
113,143
+18,867
+20% +$3.34M 0.33% 82
2021
Q2
$15.2M Buy
94,276
+63,173
+203% +$10.2M 0.28% 95
2021
Q1
$5.33M Buy
+31,103
New +$5.33M 0.12% 186
2020
Q3
Sell
-51,742
Closed -$5.91M 222
2020
Q2
$5.91M Sell
51,742
-49,211
-49% -$5.62M 0.23% 101
2020
Q1
$7.76M Buy
+100,953
New +$7.76M 0.55% 59